Sou Hu Cai Jing·2025-08-01 19:58Group 1 - The core point of the article highlights the financial performance and stock activity of ST Jingfeng (000908) as of August 1, 2025, with a closing price of 6.01 yuan, a slight increase of 0.17%, and a trading volume of 14.73 million hands, amounting to 88.27 million yuan in transaction value [1] - The company reported a total operating revenue of 100 million yuan for Q1 2025, reflecting a year-on-year decrease of 0.46%, while the net profit attributable to shareholders was 11.90 million yuan, down 960.04% year-on-year [1] - The liquidity ratios of the company are concerning, with a current ratio of 0.242, a quick ratio of 0.188, and a high debt-to-asset ratio of 102.85% [1] Group 2 - ST Jingfeng has made investments in 27 companies and participated in 13 bidding projects, indicating active engagement in business expansion [2] - The company holds 2 trademark registrations and 3 patents, showcasing its focus on intellectual property [2] - ST Jingfeng has one administrative license, which may reflect its compliance and operational capabilities within the pharmaceutical industry [2]